Posizioni attive di Gordon Brooks
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARMO BIOSCIENCES INC | Direttore/Membro del Consiglio | 21/06/2018 | - |
| DERMIRA, INC. | Direttore/Membro del Consiglio | 20/02/2020 | - |
| SIGILON THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/08/2023 | - |
Storia della carriera di Gordon Brooks
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 3 |
Settori
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Borsa valori
- Insiders
- Gordon Brooks
- Esperienza
